Examination of Sarcopenia with Obesity as a Prognostic Factor in Patients with Colorectal Cancer Using the Psoas Muscle Mass Index
Cancers · 09.10.2024 · 16 (19) · 3429
DOI: 10.3390/cancers16193429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 09.10.2024. Verfasst von Kengo Haruna und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Innovative Oncology Research and Regenerative Medicine, Osaka International Cancer Institute, Osaka 545-0871, Japan. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Sarcopenia, the age-related loss of muscle mass, is a negative prognostic factor in gastrointestinal cancer. Sarcopenia combined with visceral obesity (sarcopenic obesity) is associated with poor outcomes. We explored the influence of obesity and other factors on the prognosis of patients with colorectal cancer diagnosed with sarcopenia.
Methods
We enrolled 211 patients with colorectal cancer diagnosed with preoperative sarcopenic obesity who underwent radical resection at Osaka University Hospital between January 2009 and January 2012. Muscle mass was assessed using the psoas muscle mass index. Obesity was evaluated by measuring the visceral fat area in the umbilical region. Patients were categorized into two groups: sarcopenia with obesity (SO) and sarcopenia without obesity (non-SO). Overall survival, cancer-specific survival, and cancer-related relapse-free survival (CRRFS) were compared between the two groups. Patient characteristics, including age, sex, body mass index, serum albumin, C-reactive protein, tumor markers, prognostic nutritional index (PNI), modified Glasgow prognostic score (mGPS), and geriatric nutritional risk index (GNRI), were also analyzed.
Results
CRRFS was significantly shorter in the SO group than in the non-SO group (p = 0.028). PNI, mGPS, and GNRI were not identified as significant prognostic factors for CRRFS. Multivariate analysis highlighted sarcopenic obesity, elevated carcinoembryonic antigen levels, and unfavorable histological types as significant predictors of poor CRRFS outcomes.
Conclusions
Sarcopenic obesity is an independent predictor of poor prognosis in patients with CRC. Thus, interventions aimed at increasing muscle mass and reducing visceral fat could potentially improve the prognosis of these patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Innovative Oncology Research and Regenerative Medicine, Osaka International Cancer Institute, Osaka 545-0871, Japan.
- Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
- Department of Surgery, Osaka Police Hospital, Osaka 543-0035, Japan.
ORCID-Profile: Kengo Haruna, Soichiro Minami, Norikatsu Miyoshi, Shiki Fujino, Hidekazu Takahashi, Mamoru Uemura
Zitieren
APA
Haruna, K., Minami, S., Miyoshi, N., Fujino, S., Mizumoto, R., Toyoda, Y., Hayashi, R., Kato, S., Takeda, M., Sekido, Y., Hata, T., Hamabe, A., Ogino, T., Takahashi, H., Uemura, M., Yamamoto, H., Doki, Y., & Eguchi, H. (2024). Examination of Sarcopenia with Obesity as a Prognostic Factor in Patients with Colorectal Cancer Using the Psoas Muscle Mass Index. Cancers, 16(19), 3429. https://doi.org/10.3390/cancers16193429
Vancouver
Haruna K, Minami S, Miyoshi N, Fujino S, Mizumoto R, Toyoda Y, et al. Examination of Sarcopenia with Obesity as a Prognostic Factor in Patients with Colorectal Cancer Using the Psoas Muscle Mass Index. Cancers. 2024;16(19):3429. doi:10.3390/cancers16193429
BibTeX
@article{Haruna2024,
author = {Haruna, Kengo and Minami, Soichiro and Miyoshi, Norikatsu and Fujino, Shiki and Mizumoto, Rie and Toyoda, Yuki and Hayashi, Rie and Kato, Shinya and Takeda, Mitsunobu and Sekido, Yuki and Hata, Tsuyoshi and Hamabe, Atsushi and Ogino, Takayuki and Takahashi, Hidekazu and Uemura, Mamoru and Yamamoto, Hirofumi and Doki, Yuichiro and Eguchi, Hidetoshi},
title = {Examination of Sarcopenia with Obesity as a Prognostic Factor in Patients with Colorectal Cancer Using the Psoas Muscle Mass Index},
journal = {Cancers},
year = {2024},
volume = {16},
number = {19},
pages = {3429},
doi = {10.3390/cancers16193429}
}
EUVIMED